熱門資訊> 正文
Rapid Micro BiomSystems报告第一季度业绩
2025-05-09 19:49
- Rapid Micro Biosystems press release (NASDAQ:RPID): Q1 reports total revenue of $7.2 million, representing 28% growth compared to the first quarter of 2024.
- Reports record quarterly service revenue led by strong validation activity.
- Reports first quarter gross margin of 6%, representing a 33-percentage point improvement compared to the first quarter of 2024.
- Net loss for the first quarter of 2025 was $11.3 million, compared to $13.3 million in the first quarter of 2024. Net loss per share for the first quarter of 2025 was $0.26, compared to $0.31 in the first quarter of 2024.
- Cash, cash equivalents and short-term investments were approximately $42 million, and the Company had no debt outstanding as of March 31, 2025.
- 2025 Outlook: The Company is reaffirming its full year 2025 total revenue guidance of at least $32.0 million, with between 21 and 25 system placements.
More on Rapid Micro Biosystems
- Rapid Micro Biosystems, Inc. (RPID) Q4 2024 Earnings Call Transcript
- Seeking Alpha’s Quant Rating on Rapid Micro Biosystems
- Historical earnings data for Rapid Micro Biosystems
- Financial information for Rapid Micro Biosystems
推薦文章
華盛早報丨要求審查美聯儲！美財長貝森特激進發言；"Meme股"黑馬Opendoor再暴漲42%觸發熔斷
特朗普媒體公司囤積20億美元比特幣！加密貨幣推動特朗普淨資產大幅增長
聚焦中概 | 蔚來漲近6%，文遠知行漲逾5%
美股異動 | OPEN暴漲超41%！納微半導體大漲超25%
美股機會日報丨以太幣儲備概念股盤前大漲！穩定幣監管法案正式簽署；高盛預計美股未來12個月再漲10%
AI和機器人有望刺激特斯拉股價？財報季提前部署期權策略
華盛早報丨科技「七巨頭「財報來襲定調美股走向！金融科技公司Block獲入標普500指數
港股周報丨三家外賣平臺被約談！「瘋狂星期六」或不再瘋狂；花旗呼籲增持中國互聯網、科技及消費板塊
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
